Welcome to our dedicated page for Lam Research SEC filings (Ticker: LRCX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Lam Research Corporation (NASDAQ: LRCX) SEC filings page provides access to the company’s official regulatory disclosures, offering detailed insight into its operations as a global supplier of wafer fabrication equipment and services to the semiconductor industry. These documents are a primary source for understanding Lam’s financial performance, governance, capital structure, and key corporate decisions.
Investors can review current reports on Form 8-K, where Lam reports material events such as quarterly financial results, changes in its independent registered public accounting firm, and outcomes of stockholder meetings. For example, Lam has used Form 8-K to furnish earnings releases for quarters ended June 29, 2025 and September 28, 2025, to disclose the transition of its independent auditor from Ernst & Young LLP to KPMG LLP, and to report stockholder approval of the Lam 2025 Stock Incentive Plan and amendments to its Restated Certificate of Incorporation.
The company’s definitive proxy statement on Schedule 14A provides extensive information on corporate governance, board composition, executive compensation, equity incentive plans, and the items submitted to stockholders for vote at the annual meeting. This includes proposals related to director elections, advisory votes on executive compensation, auditor ratification, amendments to the certificate of incorporation, and stockholder proposals.
Through Lam’s annual and quarterly reports filed on Forms 10-K and 10-Q, users can examine comprehensive financial statements, management’s discussion and analysis, risk factors, and segment and geographic revenue details relevant to the semiconductor machinery manufacturing business. These filings complement the summarized data in earnings releases and help explain trends in systems revenue, customer support-related revenue, margins, cash balances, and other key metrics.
On Stock Titan, Lam Research filings are updated as they are posted to the SEC’s EDGAR system. AI-powered tools can assist by highlighting important sections, summarizing complex disclosures, and helping users locate information on topics such as stock incentive plans, auditor changes, dividend declarations, and board-authorized corporate actions. This makes it easier to interpret lengthy documents like 10-Ks, 10-Qs, and proxy statements, and to track how Lam’s regulatory reporting reflects its role in the semiconductor equipment industry.
Lam Research (LRCX) disclosed that a company director acquired 1,635 shares of common stock on 11/07/2025 at a reported price of $0.
After this transaction, the director beneficially owned 18,475 shares, held directly. The reported total includes shares subject to unvested restricted stock units.
Lam Research (LRCX) Form 4: A director acquired 1,635 shares of common stock on 11/07/2025 at a price of $0. Following this transaction, the director beneficially owns 9,664 shares.
The filing notes that the reported amount includes shares subject to unvested restricted stock units. Ownership is listed as direct.
Lam Research (LRCX) reported an insider transaction by a director. On 11/07/2025, the director acquired 1,635 shares of common stock at $0. Following the transaction, the director beneficially owned 5,322 shares directly and 560 shares indirectly via a trust. The reported direct amount includes shares subject to unvested restricted stock units.
Lam Research (LRCX) director reported the acquisition of 1,635 shares of common stock at $0 on 11/07/2025, according to a Form 4.
Following the transaction, the reporting person beneficially owned 9,135 shares, held in direct ownership. The filing notes this amount includes shares subject to unvested restricted stock units.
Lam Research (LRCX): A company director reported an equity grant on a Form 4. On 11/07/2025, the director acquired 1,635 shares of common stock at $0, typically reflecting a stock or restricted stock unit award. Following this transaction, the director beneficially owned 191,375 shares.
The reported total includes shares subject to unvested restricted stock units, and the ownership is listed as direct.
Lam Research (LRCX) filed a Form 4 reporting insider activity. A director acquired 1,635 shares of common stock at a price of $0 on 11/07/2025. Following this transaction, the director’s beneficial ownership stands at 5,342 shares, held directly.
The footnote states the reported amount includes shares subject to unvested restricted stock units.
Lam Research (LRCX) disclosed an insider equity transaction by a director. On 11/07/2025, the director acquired 1,635 shares of common stock at a reported price of $0, consistent with an equity award. Following the transaction, the director beneficially owned 288,705 shares. The filing notes that this amount includes shares subject to unvested restricted stock units.
LAM Research (LRCX) reported an insider transaction by a director. On 11/07/2025, the director acquired 1,635 shares of common stock at $0.
After the transaction, the director beneficially owned 109,995 shares, held directly. The reported total includes shares subject to unvested restricted stock units.
Lam Research (LRCX) reported director insider activity. On 11/06/2025, the director transferred 2,950 common shares to the Sohail Family Trust at $0 (Code G), shifting those holdings from direct to indirect. Following the transfer, direct ownership for that lot moved to 0, while the trust held 33,580 shares indirectly. The reporting person remains the beneficial owner of the securities held by the trust.
On 11/07/2025, the director acquired 1,635 common shares at $0 (Code A), bringing direct beneficial ownership to 1,635. The reported totals include shares subject to unvested restricted stock units.
Lam Research Corporation filed a Form S-8 to register up to 96,800,000 shares of its common stock, par value $0.001 per share, issuable pursuant to the Lam Research Corporation 2025 Stock Incentive Plan. These shares may be issued as equity compensation to eligible participants under the plan.
The filing also outlines standard Delaware indemnification provisions for directors and officers, and includes exhibits such as the 2025 Plan, legal opinion, auditor consent, and filing fee table.